NASDAQ:KTRA

Kintara Therapeutics Earning Date

USA |NASDAQ |USD

KTRA Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 10, 2021 Sep 2021 $-0.14 $-0.13 $-1.33
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 10, 2021 Sep 2021 $0.00 $0.00 $0.00

Kintara Therapeutics's next earnings date is Wednesday, Nov 10, 2021 for the fiscal quarter ending Sep 2021.

KTRA Earnings Date & History Chart

KTRA Earnings & Revenue Forecast

KTRA Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $-0.15 $-0.15 $-0.14
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 5 $-0.57 $-0.73 $-0.39
Jun 2023 4 $-0.27 $-0.64 $0.64

KTRA Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 1 / 0 $-0.21 $-0.21 $-0.21
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Jun 2022 2 / 0 $-0.68 $-0.68 $-0.68
Jun 2023 1 / 0 $-0.17 $-0.17 $-0.17

KTRA Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 3 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 4 $0.00 $0.00 $0.00
Jun 2023 4 $12.87M $0.00 $39.28M

KTRA Earnings Date & Revenue History

KTRA Earnings History

|
Show More
Show More

KTRA Revenue History

|
Show More
Show More

Kintara Therapeutics Next Earnings Date & Report

KTRA Next Earnings Date & Report Preview: Sep 2021 (FQ)

KTRA's next earnings date is Wednesday, Nov 10, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 3 analysts, the average EPS estimation for Kintara Therapeutics's next quarterly earnings is $-0.14, with a low EPS estimation of $-0.15, and a high estimation of $-0.14.

Over the last 1 month, EPS estimates have seen 1 upward revisions and 0 downward. The EPS 1 month trend is $-0.21, the last 2 month trend is $-0.21, and the 3 month trend is $-0.21.

Based on 3 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Kintara Therapeutics Previous Earnings Dates & Reports

KTRA Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Kintara Therapeutics's previous earnings date was Sep 29, 2021 for its fiscal quarter ended Jun 30, 2021.

KTRA's earnings per share (EPS) was $-0.13, beating the consensus analysts forecast of $-0.16 by 18.75%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -43.48%, and higher than the same period a year before (Jun 2020) by -60.61%.

Revenues were $0.00.

The company reported a net income of $-6.73M.

Free cash flow for the quarter was $-4.69M , compared to $-4.64M last quarter and $-2.58M a year before.

KTRA Previous Earnings Date & Report Recap: Jun 2021 (FY)

Kintara Therapeutics's previous annual earnings date was Sep 29, 2021 for its fiscal year ended Jun 30, 2021.

KTRA's earnings per share (EPS) was $-1.91, missing the consensus analysts forecast of $-1.60 by 19.37% , and lower than the previous year's EPS (Jun 2020) by 121.24%.

Revenues were $0.00.

The company reported a net income of $-38.30M.

Kintara Therapeutics reported a free cash flow of $-18.87M for its fiscal year, compared to $-7.93M a year ago.